Cholesterol & Dementia Risk: What Changes Mean
- A new study suggests that older adults with notable changes in their cholesterol levels over time may face a higher risk of developing dementia.
- Zhen Zhou, PhD, of Monash University in Melbourne, Australia, and the study's author, stated that monitoring annual cholesterol fluctuations could serve as a valuable biomarker for identifying individuals...
- Researchers tracked 9,846 participants, averaging 74 years old, without pre-existing dementia or memory issues.
Older adults, take note: A groundbreaking study reveals a notable association between fluctuating cholesterol levels and an increased risk of dementia. This research, published in Neurology, spotlights how changes in your cholesterol, especially LDL (“bad”) cholesterol, may signal potential cognitive decline.Monitoring these cholesterol fluctuations could be a crucial step in identifying individuals at risk, offering insights beyond single-point cholesterol measurements. The study, following nearly 10,000 participants, underscores a 60% higher likelihood of developing dementia in those with the most significant cholesterol swings. News Directory 3 brings you this vital update on the connection between your cholesterol levels and brain health, emphasizing the importance of long-term monitoring. discover what’s next in preventative strategies…
Fluctuating Cholesterol Levels Linked to Dementia risk
A new study suggests that older adults with notable changes in their cholesterol levels over time may face a higher risk of developing dementia. The research, published Jan. 29, 2025, in Neurology, a journal of the American Academy of Neurology, highlights a potential connection between cholesterol fluctuation and cognitive decline, independent of overall cholesterol levels.
Zhen Zhou, PhD, of Monash University in Melbourne, Australia, and the study’s author, stated that monitoring annual cholesterol fluctuations could serve as a valuable biomarker for identifying individuals at risk of dementia, potentially offering more insight than single-point cholesterol measurements. The study emphasizes an association,not a direct cause-and-effect relationship.
Researchers tracked 9,846 participants, averaging 74 years old, without pre-existing dementia or memory issues. Cholesterol was measured at the study’s start and during three subsequent annual visits. participants underwent annual memory skill tests and were monitored for an average of 5 1/2 years after the third visit. The study included participants taking statins, provided they didn’t start or stop the medication during the cholesterol measurement period.
The study divided participants into four groups based on the degree of change in their cholesterol measurements. The group with the highest cholesterol change averaged a 91 mg/dL difference between yearly measurements, while the lowest change group averaged 22 mg/dL.
During the study, 509 participants developed dementia. The group with the most significant cholesterol change saw 147 out of 2,408 people develop dementia, a rate of 11.3 per 1,000 person-years. In contrast,the group with the least change had 98 out of 2,437 people develop dementia,a rate of 7.1 per 1,000 person-years. Person-years account for both the number of participants and the duration of their involvement in the study.
After accounting for factors like age, smoking, and high blood pressure, the study found that the high-change group had a 60% greater likelihood of developing dementia compared to the low-change group. The research also linked fluctuating cholesterol levels to cognitive impairment, even in cases not meeting full dementia criteria.
Specifically, fluctuations in LDL cholesterol, often called “bad” cholesterol, showed a connection to dementia and cognitive impairment risk. No such association was found with HDL, or “good” cholesterol, or triglycerides.
zhou suggests that monitoring cholesterol for changes over time could help identify those at risk of cognitive decline or dementia. Interventions, such as lifestyle adjustments or statin use, could then be implemented to stabilize cholesterol levels and potentially reduce dementia risk.
The study acknowledges a limitation: while participants starting or stopping cholesterol medication were excluded, the study lacked information on dosage changes or adherence to prescribed medication, factors that could influence cholesterol fluctuations.
The National Heart foundation of Australia supported the research.
What’s next
Further research is needed to confirm these findings and explore the mechanisms by which fluctuating cholesterol may contribute to dementia. Future studies should also investigate the potential benefits of interventions aimed at stabilizing cholesterol levels in older adults.